Polaris Group (TPE:6550)
34.30
-0.95 (-2.70%)
Oct 31, 2025, 2:36 PM CST
Polaris Group Revenue
Polaris Group had revenue of 8.41M TWD in the quarter ending June 30, 2025, a decrease of -73.78%. This brings the company's revenue in the last twelve months to 64.02M, down -2.31% year-over-year. In the year 2024, Polaris Group had annual revenue of 107.00M with 1,330.29% growth.
Revenue (ttm)
64.02M
Revenue Growth
-2.31%
P/S Ratio
412.81
Revenue / Employee
387.97K
Employees
165
Market Cap
26.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 107.00M | 99.52M | 1,330.29% |
| Dec 31, 2023 | 7.48M | 1.04M | 16.18% |
| Dec 31, 2022 | 6.44M | -8.60M | -57.19% |
| Dec 31, 2021 | 15.04M | 5.63M | 59.84% |
| Dec 31, 2020 | 9.41M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Sunmax Biotechnology | 1.95B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Caliway Biopharmaceuticals | 44.83M |